Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Scilex Holding Co | Director | Common Stock | 2.3K | $2.28K | $0.99 | Oct 18, 2024 | Direct |
Sorrento Therapeutics, Inc. | Director | Stock option (right to buy) | 250K | Aug 30, 2021 | Direct | ||
Scilex Holding Co | Director | Nonstatutory Stock Option (right to buy) | 99K | Jun 26, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SCLX | Scilex Holding Co | Oct 18, 2024 | 1 | $990 | 4 | Oct 18, 2024 | Director |
SCLX | Scilex Holding Co | Jun 26, 2024 | 2 | $1.37K | 4 | Jun 26, 2024 | Director |
SCLX | Scilex Holding Co | Mar 15, 2024 | 1 | $0 | 4 | Jun 26, 2024 | Director |
SCLX | Scilex Holding Co | Jan 17, 2023 | 1 | $0 | 4 | Jan 17, 2023 | Director |
SCLX | Vickers Vantage Corp. I | Nov 10, 2022 | 0 | $0 | 3 | Nov 15, 2022 | Director |
SRNEQ | Sorrento Therapeutics, Inc. | Aug 30, 2021 | 1 | $0 | 4 | Aug 30, 2021 | Director |